- Home
- BANL vs PYPD Comparison
BANL vs PYPD Comparison
Compare BANL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- PYPD
- Stock Information
- Founded
- BANL 2015
- PYPD 2008
- Country
- BANL Malaysia
- PYPD Israel
- Employees
- BANL N/A
- PYPD N/A
- Industry
- BANL Oil Refining/Marketing
- PYPD Medical/Dental Instruments
- Sector
- BANL Energy
- PYPD Health Care
- Exchange
- BANL Nasdaq
- PYPD Nasdaq
- Market Cap
- BANL 25.3M
- PYPD 35.3M
- IPO Year
- BANL 2023
- PYPD 2020
- Fundamental
- Price
- BANL $0.90
- PYPD $3.59
- Analyst Decision
- BANL
- PYPD Strong Buy
- Analyst Count
- BANL 0
- PYPD 5
- Target Price
- BANL N/A
- PYPD $11.40
- AVG Volume (30 Days)
- BANL 1.8M
- PYPD 1.4M
- Earning Date
- BANL 04-16-2025
- PYPD 08-13-2025
- Dividend Yield
- BANL N/A
- PYPD N/A
- EPS Growth
- BANL N/A
- PYPD N/A
- EPS
- BANL N/A
- PYPD N/A
- Revenue
- BANL $592,517,545.00
- PYPD N/A
- Revenue This Year
- BANL N/A
- PYPD N/A
- Revenue Next Year
- BANL N/A
- PYPD N/A
- P/E Ratio
- BANL N/A
- PYPD N/A
- Revenue Growth
- BANL 35.93
- PYPD N/A
- 52 Week Low
- BANL $0.55
- PYPD $2.30
- 52 Week High
- BANL $1.35
- PYPD $4.49
- Technical
- Relative Strength Index (RSI)
- BANL 54.01
- PYPD 59.00
- Support Level
- BANL $0.81
- PYPD $3.12
- Resistance Level
- BANL $1.03
- PYPD $3.75
- Average True Range (ATR)
- BANL 0.11
- PYPD 0.29
- MACD
- BANL 0.02
- PYPD 0.01
- Stochastic Oscillator
- BANL 73.68
- PYPD 69.83
About BANL CBL International Limited
CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.